- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypsarrhythmia and/or infantile spasms
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 789KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 35KB)
Tetracosactide – March 2021
Tetracosactide: Compound depot injection 1 mg in 1 mL; Synacthen®
Last updated
16 July 2021